☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Novartis Reports P-III (MONALEESA-2/3/7) Study Results of Kisqali (ribociclib) for HR+/HER2- Advanced Breast Cancer
September 9, 2022
PharmaShots Weekly Snapshots (September 05 - 09, 2022)
September 9, 2022
Pfizer Reports the US FDA and EMA's Acceptance of NDA & MAA for Ritlecitinib to Treat Alopecia Areata in Patients Aged ≥12 Years
September 9, 2022
Abbott Launches Amplatzer Talisman PFO Occlusion System for the Treatment of Patent Foramen Ovale in the EU
September 9, 2022
Regeneron Reports (PHOTON) and (PULSAR) Study Results of Aflibercept for Diabetic Macular Edema and Wet Age-Related Macular Degene...
September 9, 2022
Eli Lilly Presents P-III (ADvocate 1 & 2) Trial Results of Lebrikizumab for the Treatment of Atopic Dermatitis at EADV 2022
September 9, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions